Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

MAP 2018 - Molecular Analysis for Personalised Therapy

14 - 15 Sep 2018

Paris, France

MAP 2018 - Square

Resources from MAP 2018 - Molecular Analysis for Personalised Therapy are available to ESMO member according to the presenters' agreement to release them.

The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

MAP 2018 - Square

The development of new biotechnologies and their application to Precision Medicine in cancer treatment is a fast-moving field. Understanding molecular alterations, their mechanisms of action and how they can apply to therapy is a challenge in medical oncology and clinical practice.

MAP 2018 is a joint initiative of Cancer Research UK, UNICANCER and ESMO and aims to provide oncologists with expert guidance on interpreting genomic alterations to design tailored treatment programmes for their patients.

Filter by:

There are 143 resources available


Presenter: Laurence Zitvogel

Session: Linking infectious disease and cancer: Impact on cancer precision medicine

Genomic-driven trials

Presenter: Rodrigo Dienstmann

Session: Innovative clinical trials




This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings